George Millen: Unscripted

How did Pollard Banknote's subsidiary lock in a key Colorado Lottery contract? A 17% sales boost from digital tech proved its value.

Cadrenal Therapeutics appoints Dr. Lee Golden to its board, a strategic move signaling a push to accelerate its pipeline in a competitive market.

As ProQR prepares for its Evercore chat, investors weigh the promise of its unique RNA editing platform against a field of biotech giants.

A permit delay at a historic silver mine in Peru tests Carlton Precious, highlighting the clash between rich resources and tough environmental rules.

EnviroGold Global is deploying mobile pilot plants to unlock trillions in mine tailings. Is this strategic pivot the key to dominating the green metals race?

Karolinska Development seeks a massive capital injection, risking huge shareholder dilution to fund a promising drug pipeline and rebrand as KDventures.

Saba's BRW fund boasts a double-digit yield, but over half is a return of capital. We decode what this financial engineering means for investors.

A temporary mill shutdown at Conifex reveals the harsh reality of trade wars and a housing slump squeezing Canada's vital softwood lumber industry.

With 132% revenue growth and sustained profitability, Hydreight's platform strategy is rewriting the rules for at-home healthcare delivery and investment.

Pender Growth Fund reports a Q3 net loss, yet shareholder equity climbs. We dissect the numbers, the buybacks, and the strategy behind the contradiction.

Southwest Gas promotes Justin Forsberg to CFO, a strategic move that cements its pivot to a pure-play utility and signals a focus on stable growth.

Halmont Properties posts strong revenue growth from its prime real estate and forestry assets, but a dip in EPS raises questions about shareholder value.

Moleculin Biotech's 1-for-25 reverse split aims to save its Nasdaq spot, but a history of dilution casts a shadow over its promising cancer drug pipeline.

Prestige Wealth rebrands as Aurelion, using $150M in new capital to bet its future on tokenized gold. Is this a brilliant move or a desperate gamble?

With a fresh $26.4M, Volatus isn't just growing; it's arming for the future. We analyze the strategic play to dominate the defense drone market.

Micro-cap Xeriant taps a decorated general to lead a 'Skunk Works' lab. Is it a genius move to disrupt tech or a desperate gamble for a cash-strapped firm?

A new API certification signals OMS Energy's strategic pivot to dominate Southeast Asia, backed by a strong balance sheet and a plan to challenge the giants.

Buried by legacy claims, Asbestos Corporation navigates a complex cross-border bankruptcy. Who pays for survival when the parent company is first in line?

KeyCorp's early note redemption seems minor, but it signals robust financial health and a savvy banking trend. Here’s what it means for investors.

Golar's $1.2B deal for its floating gas factory proves the tech's bankability, providing a massive cash injection for future growth and shareholder returns.